Click here to

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

3 | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | show all

Keywords: TCP
MO-C930-IePD-F5-3Radiotherapy Induced Xerostomia Prediction Through Cluster Models Incorporating 3D Spatial Dose Within the Parotid Gland and Machine Learning Techniques
M Chao1*, I. El Naqa2, R. Bakst1, Y. Lo1, J. A. Penagaricano2 (1) The Mount Sinai Medical Center, New York, NY, (2) Moffitt Cancer Center, Tampa, FL
PO-GePV-M-117Toward Offline Adaptive Therapy for Prostate Patients Using Velocity
E Bacon1*, S Wisnoskie2, M Hyun2, (1) Creighton University, Omaha, NE, (2) University of Nebraska Medical Center, Omaha, NE
PO-GePV-M-128Evaluation of the Clinical Impact of the Differences Between Planned and Delivered Doses in Prostate Cancer Radiotherapy Based On Daily IGRT and Patient-Reported Outcome Scores
P Mavroidis1*, J Hammers2, G Narayanasamy3, S Sud4, D Lindsay5, X Tan6, J Dooley7, S Stathakis8, L Marks9, R Chen10, S Das11, (1) University of North Carolina, Chapel Hill, NC, (2) Chapel Hill, NC, (3) University of Arkansas for Medical Sciences, Little Rock, AA, (4) University Of North Carolina At Chapel Hill, NC, (5) UNC at Chapel Hill, Chapel Hill, NC, (6) UNC at Chapel Hill, Chapel Hill, NC, (7) University of North Carolina, Chapel Hill, NC, (8) Mays Cancer Center - MD Anderson Cancer Center, San Antonio, TX, (9) University of North Carolina at Chapel Hill, Chapel Hill, NC, (10) University Of Kansas, (11) University of North Carolina, Chapel Hill, NC
PO-GePV-M-313Quantitative Modeling On Tissue-Specific Stem Cell Amounts for Radiation Induced Normal Tissue Complications
K Wang*, M Huq, UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine, Pittsburgh, PA
PO-GePV-M-340AI-Assisted TCP/NTCP Predication Model for HNSCC Patients to Aid Treatment Plan Evaluation
A Saad Bin Saeed1*, M Pudasaini1, A Khan2, W Muhammad1, (1) Florida Atlantic University, Boca Raton, Florida, (2) Aga Khan University Hospital,
PO-GePV-T-111Improvements On Acute Gastrointestinal Toxicity Modeling by Using Deep-Learning Auto-Segmentation
R Salazar*, J Duryea, A Leone, S Nair, R Mumme, H Baroudi, T Netherton, E Holliday, T Whitaker, K Hoffman, L Court, J Niedzielski, UT MD Anderson Cancer Center, Houston, TX
PO-GePV-T-115NTCP Modeling of Dysphagia 12 Months After Radiotherapy for Oropharyngeal Cancer Using the EAT10, CTCAE and PRO-QoL Scoring Systems
A Tzikas1*, E Lavdas2, D Kehayas3, R Amdur4, W Mendenhall5, N Sheets6, S Stathakis7, R Green8, L Marks9, S Das10, B Chera11, P Mavroidis12, (1) University Of West Attica, Department Of Biomedical Sciences, Athens, Greece, (2) University of West Attica, Athens, Greece, (3) University Of West Attica, Athens, Greece, (4) University of Florida Hospitals, Gainesville, FL, (5) University of Florida, Gainesville, FL, (6) Duke University, Raleigh, NC, (7) Mays Cancer Center - MD Anderson Cancer Center, San Antonio, TX, (8) UNC at Chapel Hill, NC, (9) University of North Carolina at Chapel Hill, Chapel Hill, NC, (10) University of North Carolina, Chapel Hill, NC, (11) UNC at Chapel Hill, NC, (12) University of North Carolina, Chapel Hill, NC
PO-GePV-T-125Computerized Risk Modeling of Imaging Changes and Radionecrosis After Proton Beam Therapy for Childhood Brain Tumors
F Heinzelmann1,2,3*, C Baeumer1,2,3,4, S Peters1,5, A Stock6, S Schulze-Schleithoff1, S Frisch1, B Timmermann1,3,4,5,7, (1) West German Proton Therapy Center Essen (WPE), Essen, NW, DE, (2) TU Dortmund University, Department of Physics, Dortmund, NW, DE, (3) University Hospital Essen, West German Cancer Center (WTZ), Essen, NW, DE, (4) German Cancer Consortium (DKTK), Heidelberg, NW, DE, (5) University Hospital Essen, Department of Particle Therapy, Essen, NW, DE, (6) University Hospital Wuerzburg, Department of Neuroradiology, Wuerzburg, BY, DE, (7) University of Duisburg-Essen, Faculty of Medicine, Essen, NW, DE
PO-GePV-T-275Breast Conformal Radiotherapy with Sequential Boost Versus Intensity-Modulated Radiation Therapy with a Simultaneously Integrated Boost
G Komisopoulos1*, P Mavroidis2, F Simopoulou3, G Kyrgias1, N Papanikolaou4, K Theodorou1, (1) Medical School, University of Thessaly, Larissa, Greece,(2) University of North Carolina, Chapel Hill, NC, (3) Iaso Thessaly Medical Center, Larissa, Greece, (4) University of Texas HSC SA, San Antonio, TX
PO-GePV-T-346Dosimetric and Radiobiological Evaluation of the Dose Distributions From the Treatment Plan and Logfiles in Head & Neck Radiotherapy
T Cuthbert1*, P Mavroidis2, W Jones3, S Stathakis4, (1) UT Health Sciences Center, San Antonio, TX, (2) University of North Carolina, Chapel Hill, NC, (3) University of Texas HSC San Antonio, San Antonio, TX,(4) Mays Cancer Center - MD Anderson Cancer Center, San Antonio, TX
SU-F-206-5Deep Learning Dose Prediction as a Tool to Evaluate Treatment Complications Based On NTCP Models
C Draguet1,2*, A Barragan Montero1, P Populaire2,3, G Defraene2, M Thomas2,3, K Haustermans2,3, J Lee1, E Sterpin1,2, (1) UCLouvain - Institut de Recherche Experimentale et Clinique - Molecular Imaging Radiotherapy and Oncology (MIRO), Brussels, BE, (2) KULeuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Leuven, BE, (3) University Hospital Leuven, Department of Radiation Oncology, Leuven, BE
SU-H430-IePD-F7-2NTCP Modeling of Xerostomia 12 Months After Radiotherapy for Oropharyngeal Cancer Using the PRO-CTCAE Scoring System
A Tzikas1*, E Lavdas2, D Kehayas3, R Amdur4, W Mendenhall5, N Sheets6, S Stathakis7, R Green8, L Marks9, S Das10, B Chera11, P Mavroidis12, (1) University Of West Attica, Department Of Biomedical Sciences, Athens, Greece, (2) University of West Attica, Athens, Greece, (3) University Of West Attica, Athens, Greece, (4) University of Florida Hospitals, Gainesville, FL, (5) University of Florida, Gainesville, FL, (6) Duke University, Raleigh, NC, (7) Mays Cancer Center - MD Anderson Cancer Center, San Antonio, TX, (8) UNC at Chapel Hill, NC, (9) University of North Carolina at Chapel Hill, Chapel Hill, NC, (10) University of North Carolina, Chapel Hill, NC, (11) UNC at Chapel Hill, NC, (12) University of North Carolina, Chapel Hill, NC
SU-K-206-2Analytical Modeling of Intertrack Interaction in Ultra-High Dose Rate (FLASH) Radiotherapy
A Baikalov1,2,3*, R Abolfath4, R Mohan4, J J Wilkens2, S Bartzsch2,3, (1) Technical University of Munich, Garching, DE, (2) Klinikum rechts der Isar, Munich, DE, (3) Helmholtz Zentrum Muenchen GmbH, German Research Center for Environmental Health, Neuherberg, DE, (4) UT MD Anderson Cancer Center, Houston, TX
SU-K-206-3Does Reduction of Variable RBE-Weighted Dose in Organs at Risk Impact Clinical Proton Plan Quality?
L Heuchel1*, C Hahn1,2,3, J Oeden4, E Traneus4, J Wulff5,6, S Plaude5,6, B Timmermann5,6,7,8, C Baeumer1,5,6,8, A Luehr1, (1) Department of Physics, TU Dortmund University, Dortmund, Germany, (2) OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, (3) Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Gerrmany, (4) RaySearch Laboratorie AB, Stockholm, Sweden, (5) West German Proton Therapy Centre Essen, Essen, Germany, (6) West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany, (7) Department of Particle Therapy, University Hospital Essen, Essen, Germany, (8) German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
TH-D-BRC-5Normal Tissue Complication Modeling for Radiation-Induced Lymphopenia After Abdominal Radiotherapy
S Kim1*, H Byun2, W Sung1, ((1) Department of Biomedical Engineering and Biomedicine & Health Science, College of Medicine, The Catholic University of Korea, Seoul, KR (2) Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, KR

Share: